• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • Cassio Fernando da Silva, Brazil

    Cassio Fernando da Silva, Brazil

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Susan Keldani, USA

    Susan Keldani, USA

  • Ann Nicol, USA

    Ann Nicol, USA

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Dick Dayton, USA

    Dick Dayton, USA

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • David Bishop, UK

    David Bishop, UK

  • Art Eggert, USA

    Art Eggert, USA

  • Ali Var, Turkey

    Ali Var, Turkey

  • David Hall, USA

    David Hall, USA

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • Len Johnrose, England

    Len Johnrose, England

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Susan Anderson, USA

    Susan Anderson, USA

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Jean Waters, UK

    Jean Waters, UK

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • David Solomon, UK

    David Solomon, UK

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login